BioCentury | Oct 5, 2018
Company News

Momenta cutting biosimilar programs, headcount

...Momenta Pharmaceuticals Inc. (NASDAQ:MNTA), Cambridge, Mass. Business: Biosimilars, Autoimmune Mary Romeo biosimilar abatacept (M834) biosimilar adalimumab (BAX 923, M923) Biosimilar aflibercept...
Items per page:
1 - 1 of 1